Centaurus Financial’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Centaurus Financial’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-56,999	Closed	-$2.63M	–	993
2021 Q4	$2.63M	Buy	+56,999	New	+$2.7M	0.2%	137
2021 Q3	–	Sell	-26,028	Closed	-$1.35M	–	961
2021 Q2	$1.35M	Buy	26,028 +23,903	+1,125%	+$1.2M	0.11%	219
2021 Q1	$107K	Sell	2,125 -21,946	-91%	-$1.17M	0.01%	770
2020 Q4	$1.25M	Buy	24,071 +21,716	+922%	+$1.04M	0.13%	189
2020 Q3	$102K	Hold	2,355	–	–	0.01%	623
2020 Q2	$101K	Buy	+2,355	New	+$97.3K	0.01%	602
2020 Q1	–	Sell	-14,270	Closed	-$652K	–	672
2019 Q4	$652K	Buy	+14,270	New	+$566K	0.09%	252
2019 Q1	–	Sell	-3,000	Closed	-$102K	–	584
2018 Q4	$102K	Hold	3,000	–	–	0.02%	461
2018 Q3	$132K	Buy	3,000 +290	+11%	+$13.7K	0.02%	459
2018 Q2	$117K	Sell	2,710 -150	-5%	-$6.3K	0.02%	659
2018 Q1	$120K	Buy	+2,860	New	+$125K	0.03%	406

Other funds holding XPH

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $26.6B AUM 22.97% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

FFM

Fullerton Fund Management Singapore $1.56B AUM 88.19% 1-Year Est. Return

Centaurus Financial's XPH Position: Q1 2022 in Review

Centaurus Financial sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q1 2022, closing a stake of 56,999 shares — an estimated $2.63M sold.

Centaurus Financial first reported a position in XPH in Q1 2018 and held it in 11 quarters. The position peaked at $2.63M in Q4 2021. 69 funds tracked by Wall St. Rank hold XPH as of Q1 2022.

Centaurus Financial reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q1 2022 after selling out during the quarter.
Centaurus Financial sold 56,999 State Street SPDR S&P Pharmaceuticals ETF shares in Q1 2022, an estimated $2.63M.
Centaurus Financial first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q1 2018 and held it in 11 quarters.
Centaurus Financial's State Street SPDR S&P Pharmaceuticals ETF position peaked at $2.63M in Q4 2021.
69 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q1 2022.

Based on Centaurus Financial's 13F filing for Q1 2022, filed 13 May 2022.